Moody’s Corporation (NYSE: MCO) — The Toll Bridge the Market Mistook for a Data Vendor

Independent Equity Research Report date: 2026-06-13 · Price referenced: ~$447.85 (close 2026-06-12) · ~177.5M diluted shares · Market cap ~$79.5B · EV ~$84B

⚡ Claude’s Take

This block is the author’s own subjective opinion. It is general information, not investment advice, and reflects a personal, independent view. The analysis that follows carries no recommendation and no price target — it discusses valuation only as embedded expectations and scenarios.

Verdict: BUY for long-term compounders — accumulate on weakness. Attractive below ~$450 (≈27x forward EPS); compelling sub-$420 (≈25x). HOLD-and-add, not a fresh-money table-pound at the highs. Not a short under any circumstance. Conviction: medium-high.

Moody’s is one of the highest-quality franchises in public equities — a regulatorily-protected ratings duopoly (with S&P) earning a 63.6% operating margin on the toll it collects from nearly every new bond, bolted to a sticky, high-single-digit-compounding analytics subscription business. Fundamentals are at record levels (FY2025 revenue $7.7B, adjusted operating margin >50%, ROIC 26%, Q1 2026 EPS +13%), yet the stock has de-rated ~12% year-to-date, sits below its 200-day average, and carries negative price momentum and negative alpha. The factor tape confirms it: this is an out-of-favor quality name the momentum crowd has abandoned — not a falling knife (the business is accelerating, not deteriorating). Crucially, the AI-disruption fear driving the sector sell-off is mis-located onto the wrong segment: ~70% of Moody’s segment profit sits in ratings (MIS), which is AI-immune — a credit rating’s value is the market’s collective agreement to require and trust it, a coordination good no LLM can replicate — while the AI-exposed analytics segment is only ~30% of profit, and even there Moody’s is monetizing AI (the Microsoft Copilot and Anthropic/Claude integrations) rather than being hollowed out by it. The reverse-DCF math says the current price embeds only ~5–6% perpetual growth, undemanding for a franchise that should compound earnings low-teens. The single honest caveat is that the absolute multiple (32x trailing) leaves no room for a serious MIS issuance freeze, and the own-history valuation percentile (53rd) says this is mid-of-its-own-range, not screamingly cheap — hence “accumulate on weakness,” not “back up the truck.”

Framing: quality-compounder-at-a-fair-price / out-of-favor quality. Tag: “The toll bridge the market mistook for a data vendor.” Bull-flip trigger: MA recurring-revenue (ARR) growth re-accelerates toward double digits and AI data-licensing revenue becomes a disclosed line — proof the analytics moat is widening, not eroding. Bear-flip trigger: MA organic growth decelerates and Data & Information retention/pricing cracks (AI substitution turning real), or a sustained 2022-style issuance freeze that the 32x multiple cannot absorb.

1. Executive Summary

Moody’s Corporation is a two-segment risk-assessment franchise: Moody’s Investors Service (MIS), the credit-ratings business (~53% of FY2025 revenue, ~70% of segment profit), and Moody’s Analytics (MA), a data/research/software subscription business (~47% of revenue, ~30% of profit). The economic heart of the company is MIS — half of a global ratings duopoly with S&P Global that has earned 60%+ operating margins for decades behind one of the most durable moat-stacks in finance: a government-granted NRSRO license, the market convention of two ratings per major bond issue, and a century-plus reputation that regulators and investors mandate by name.

The numbers are excellent and improving. FY2025 revenue grew to $7,718M (+9%), adjusted operating margin reached ~51%, diluted EPS hit $13.67 (up 84% from the 2022 trough of $7.44), ROIC was 26.1%, and the company converted earnings to $2.9B of free cash flow, returning ~83% of it to shareholders ($701M dividends + $1.7B buybacks). Q1 2026 was a record quarter: both segments grew 8%, adjusted operating margin expanded 150bps to 53.2%, and adjusted EPS rose 13% to $4.33. Management guides FY2026 to $16.40–$17.00 adjusted EPS (~+12% at the midpoint).

The investment tension is valuation against cyclicality and an AI narrative, not business quality. At ~$448 the stock trades at ~32x trailing / ~27x forward earnings and ~21x EV/EBITDA. That is a full price in absolute terms — but it is only the 53rd percentile of Moody’s own ~10-year valuation range, and the stock has de-rated ~12% in 2026 even as earnings set records. The market appears to be pricing two fears: (1) that 2025’s strong debt issuance marks a cyclical peak for MIS, and (2) that generative AI commoditizes Moody’s data and research. Our analysis finds the first is a real but manageable cyclical risk (the refinancing “maturity wall” and secular debt growth support issuance volumes), and the second is largely mis-located — the AI threat lands on MA (the smaller, lower-margin segment), while the dominant MIS profit pool is structurally AI-immune. This report takes no position; it lays out the evidence, the embedded expectations, and the falsification tests for each side.

2. Business Overview

Moody’s makes money two distinct ways, and conflating them is the single most common analytical error in the name.

Moody’s Investors Service (MIS) — the ratings toll road. MIS earned $4,119M of external revenue in FY2025 (~53% of the total). Its economic model is issuer-pays: when a company, bank, sovereign, or structured vehicle issues debt, it pays Moody’s a transaction fee to rate the instrument, then pays recurring monitoring/surveillance and annual relationship fees for as long as the debt is outstanding. The marginal cost of rating one more bond is essentially analyst time; the value to the issuer — market access and a lower cost of capital — is large. That asymmetry produces the franchise’s defining financial signature: a 63.6% adjusted operating margin (FY2025, up from 60.1% in FY2024). MIS revenue breaks into four lines of business:

The cyclicality is concentrated in Corporate Finance (especially leveraged finance), which swings with debt-market conditions. Within MIS, FY2025 revenue is ~64% transactional / ~36% recurring (surveillance + relationship fees).

Moody’s Analytics (MA) — the subscription annuity. MA earned $3,599M of external revenue in FY2025 (~47%) at a 33.1% adjusted operating margin. It sells data, research, and workflow software, organized into three lines:

MA’s economics are the inverse of MIS: ~57% recurring, with ~95%+ retention and $3,498M of annualized recurring revenue (ARR), +8% YoY. Management is deliberately retiring one-time transaction revenue (down ~18% in FY2025) to convert customers to cloud subscriptions — a mix shift that lowers near-term reported MA growth but raises its durability.

Consolidated: ~54% transactional / 46% recurring; >50% of revenue is non-US (MA is majority international, with EMEA its largest geography; MIS bills the majority of ratings revenue outside the US). The business is capital-light — ~$110M capex on $7.7B revenue (~1.4%) — and converts net income to cash above 1.0x. Moody’s also holds minority stakes in local agencies (e.g., 30% of China’s CCXI).

A note on history and identity. The company traces to John Moody’s 1900 manual of securities statistics and his 1909 innovation — selling letter-grade bond ratings to investors. The economic model later inverted to issuer-pays (the source of the perennial conflict-of-interest critique), and the modern corporate entity emerged from the September 2000 spin-off of Dun & Bradstreet. The two-segment shape — a ratings agency plus an analytics business built largely by acquisition (the 2008 financial crisis pushed Moody’s to diversify away from pure ratings dependence) — is the deliberate result of two decades of capital allocation: use the ratings cash gusher to build a recurring-revenue analytics annuity that dampens the issuance cycle. That strategic logic is why the MA segment exists and why management measures it on ARR rather than reported revenue.

Why the two segments behave so differently. MIS revenue is event-driven: it is recognized when a debt instrument comes to market, so it tracks the flow of new and refinanced issuance, which in turn tracks rates, spreads, and risk appetite. A single quiet quarter in leveraged finance can swing Corporate Finance revenue by double digits. MA revenue is stock-driven: it is the sum of subscription contracts on the books, so it grows with net new bookings and price, and it falls only if customers churn — which, at ~95% retention, they rarely do. The investment implication is that MIS is a high-margin call option on the credit cycle, and MA is a bond-like annuity; blending them produces a business whose earnings level is cyclical but whose earnings floor (recurring MIS surveillance + MA ARR ≈ $5.0B of revenue) is remarkably stable. In the 2022 freeze, that recurring floor is what kept margins in the mid-30s% rather than collapsing.

Verdict (Business model): A toll-road on global debt issuance (MIS) welded to a sticky subscription annuity (MA). The quality of the whole is carried by MIS; MA adds durable recurring growth and AI optionality. Capital-light, cash-generative, globally diversified, with a ~$5B recurring-revenue floor under a cyclical top line.

3. Industry Dynamics

The ratings industry is one of the best industry structures in all of finance. The “Big Three” — S&P, Moody’s, Fitch — hold roughly 95% of the global ratings market; S&P and Moody’s together account for ~80% of the international market, with Fitch ~15% and a long tail (DBRS Morningstar, KBRA, AM Best, JCR, HR Ratings) splitting the rest. US share by outstanding ratings has been stable for over 15 years at roughly S&P ~49% / Moody’s ~34% / Fitch ~13–15%. As of year-end 2024 there were ten registered NRSROs, yet the competitive structure has not meaningfully moved — new entrants have come and gone without displacing the incumbents.

Three reinforcing barriers explain this stability, and it is rare for all three of Greenwald’s genuine advantage types to stack in one industry:

1. Regulatory license (barrier to entry). A Nationally Recognized Statistical Rating Organization (NRSRO) registration is required for ratings to count toward bank/insurer regulatory capital, mandate eligibility, and index inclusion. Dodd-Frank’s Rule 17g compliance regime raised the cost of operating as a rating agency — policing incumbents but also moating them against would-be entrants. The EU equivalent is ESMA oversight. This is a legal wall.
2. Economies of scale + the two-rating convention (demand captivity). Most large bond issues carry two ratings, and the default pair is S&P and Moody’s. A new entrant must displace an incumbent on a syndicate’s checklist, not merely be analytically competent — a coordination problem that protects the dominant pair.
3. Intangible / reputation. A century-plus track record that investors and regulators reference by name cannot be bought or rebuilt on any relevant timeframe.

The demand backdrop is supportive. Global debt maturities are climbing toward a ~$2.78T peak in 2026 (S&P Global Credit Trends), with roughly a third of US debt maturing that year. Refinancing demand is largely non-discretionary — maturing debt must be reissued and re-rated — providing a structural floor under MIS volumes that is independent of risk appetite. Layered on top are fresh issuance pools: AI-infrastructure/hyperscaler capital expenditure funded in the investment-grade market, private-credit growth, and the energy transition.

The Marathon capital-cycle read is the tell. Normally, high returns attract capital that competes them away. In ratings, the NRSRO license, reputation, and two-rating convention block that mechanism: capital has tried to enter (KBRA, DBRS) for 15 years, yet incumbent share and margins are stable. Where the capital cycle is operating is the contested adjacency — private credit and financial data/analytics — into which capital is flooding (private-credit AUM ~$1.7T heading toward ~$5T by 2029; consolidation like LSEG/Refinitiv and BlackRock/Preqin). That is the textbook signal: the moated core resists mean-reversion; the unmoated edge attracts the competition. Moody’s profit is concentrated in the moated core.

The value chain and where the profit pools sit. In the credit-issuance value chain — issuer → underwriter/bank → rating agency → investor → index/benchmark → data/analytics vendor → regulator — the rating agency occupies a structurally privileged node: it is a mandatory gate (regulatory and convention-driven) that sits between issuer and investor, charges a small fee relative to the size of the financing, and bears no balance-sheet or distribution risk. Compare the economics across the chain: underwriting banks earn low-single-digit fees on enormous capital with cyclical, competed-away returns; index providers (MSCI, S&P Dow Jones Indices) earn 50%+ margins on a similar license-and-convention moat; data vendors earn 20–35%; the rating agencies earn 60%+. The two highest-margin nodes — ratings and indices — share the same economic DNA: a standard the market has agreed to coordinate around, monetized as a toll, immune to the marginal cost of one more unit. This is why Moody’s and S&P, MSCI, and (in payments) Visa/Mastercard all screen as the same kind of asset: regulatory/convention-protected toll collectors. It also frames the AI debate correctly — AI compresses the analysis/data nodes of the chain, not the coordination-standard nodes.

Regulatory structure — a double-edged moat. Post-2008, the rating agencies became the political scapegoat for the structured-finance blow-up, and the regulatory response (Dodd-Frank Title IX, the SEC Office of Credit Ratings, EU CRA Regulation and ESMA supervision) imposed a heavy, ongoing compliance regime: methodology transparency, conflict-of-interest controls, look-back reviews, and the threat of liability. The counterintuitive result is that this regime raised barriers to entry — a new NRSRO must build the same compliance infrastructure to compete for a fraction of the volume — and it institutionalized the agencies as quasi-utilities the financial system is built around. The standing tail risk is a regime change to the issuer-pays model itself (an investor-pays or government-utility model has been floated for 15 years and never enacted); short of that, regulation is a moat-widener, not a moat-threat.

The MA arena — Bloomberg, LSEG, FactSet, S&P Market Intelligence, MSCI, Morningstar — is structurally good but contested, with industry margins of 20–35% versus ratings’ 60%+, and it is where the generative-AI substitution thesis is genuinely credible.

Verdict (Industry): Two-tier, blended HIGH. Ratings (MIS) is structurally excellent — a regulatorily-protected, scale-and-reputation oligopoly that has resisted the capital cycle for decades. Financial data/analytics (MA) is above-average but contested and AI-exposed. Because profit concentrates in the protected tier, the blended industry quality is high.

4. Competitive Position

MIS — a wide, durable moat that is AI-immune. Moody’s ratings franchise possesses Greenwald’s full advantage stack simultaneously: a government license (NRSRO), customer captivity (the two-rating convention plus the reputational penalty an issuer pays for firing a rater mid-program), and economies of scale plus intangible reputation. It passes both diagnostic tests cleanly:

• Market-share-stability test: PASSED emphatically — Moody’s US share has held near 34% for decades.
• ROIC test: PASSED — consolidated ROIC of 26.1% (FY2025), with MIS standalone economics far higher given its capital-light 63.6% margin.

The decisive point for the current debate is that MIS is structurally immune to AI substitution. A credit rating’s value is not the analytical computation behind it (which AI cheapens) but the market’s collective agreement to require and trust it — a coordination good that no large language model can manufacture. If anything, AI is net-accretive to MIS: it lowers Moody’s own cost to produce and surveil ratings, which is visible in the +350bps year-over-year margin expansion to 63.6%. You cannot prompt your way around a legally required NRSRO rating.

MA — a narrower but real moat, and a better one than the peer’s. MA’s defenses are switching costs plus proprietary data/intangibles, not a coordination standard — so the moat is genuine but more contestable than MIS. The evidence of durability is solid: ARR +8%, ~95%+ retention, KYC ARR +15%, and deepening workflow lock-in as customers migrate to cloud subscriptions. The Data & Information layer rests on Orbis/BvD, the world’s largest hand-assembled company and credit database, which is not replicable by scraping. Critically, MA is positioned away from the generic-terminal fight — it competes on proprietary credit research and regulated workflow software (KYC/AML, insurance, banking), not as a Bloomberg-substitute terminal. This is why MA earns a 33% margin versus the ~20% of S&P’s analogous Market Intelligence segment (based on S&P Global’s reported segment disclosures): it is a materially higher-quality version of the same business.

The AI threat is real but mis-located. The 2025–26 sell-off in financial-information stocks — “swift and indiscriminate,” driven by fear that AI erodes data-vendor moats — treats Moody’s like a terminal vendor an LLM will hollow out. But ~70% of segment profit is in AI-immune MIS, and the AI-exposed MA segment is only ~30% of profit. Even within MA, Moody’s is defending by embedding: distributing decision-grade data into Microsoft 365 Copilot and Excel, deploying its own GenAI assistant on CreditView, and — notably — making its agentic credit and compliance workflows natively available inside Anthropic’s Claude environment via a first-of-its-kind application. AI is being turned into a distribution channel and a data-licensing TAM expander rather than a substitute.

Head-to-head with the twin (S&P Global). The cleanest way to pressure-test MCO’s moat is against its near-identical competitor, S&P Global — the factor model puts the two at 0.957 similarity, the highest of any pair in the complex. Both are halves of the ratings duopoly; the difference is in the second segment.

The read: SPGI has the larger ratings share and the crown-jewel index business (S&P 500 licensing), so it is arguably the higher-quality conglomerate overall. But on the contested analytics piece, Moody’s Analytics is the better-run business — a 33% margin vs. S&P MI’s ~20%, because MA leans on proprietary credit data (Orbis/BvD) and regulated workflow software rather than fighting as a generic terminal. The investment nuance: MCO is a more concentrated bet on the ratings/credit-analytics franchise (no index ballast), which makes it slightly more cyclical and slightly cheaper — and, in 2026, more directly in the crosshairs of the AI-data-vendor narrative despite the same underlying moat.

Where the moat is genuinely testable: (a) the Data & Information LOB ($912M) is the most substitutable MA line — its retention and pricing are the cleanest bear falsification signal; (b) private-credit disintermediation could, in theory, route financing around public ratings or toward cheaper NRSROs via ratings-shopping — though insurer-held private credit increasingly seeks ratings, making this a swing factor rather than a clear negative; © the surveillance/recurring portion of MIS revenue ($1.5B) is a proxy for the stock of rated debt — if it ever shrinks, it signals the rated-bond universe itself is contracting, the deepest possible bear signal for the core.

Verdict (Moat): MIS — WIDE and durable, regulatory + captivity + scale/reputation, AI-immune. MA — narrow-to-moderate, switching costs + proprietary data, partially AI-exposed but better-defended than peers. Consolidated, a genuinely wide-moat franchise because the dominant profit pool sits behind the strongest possible walls. The duopoly is not meaningfully assailable by competitors; the real (still modest) risks are regulatory regime-change to issuer-pays and AI/private-credit erosion of the MA edge — not displacement of the ratings core.

5. Growth History and Forward Opportunities

History. Revenue ran $5,371M (2020) → $6,218M (2021) → $5,468M (2022 trough, –12%) → $5,916M (2023) → $7,088M (2024) → $7,718M (2025). The 2022 trough is the single most instructive episode in the financials: the Fed’s rapid hiking cycle froze bond issuance, MIS transaction revenue collapsed, and EPS fell 37% to $7.44. Yet MIS margins compressed only to the mid-30s% — the business stayed highly profitable through the worst issuance environment in over a decade, demonstrating that the cyclicality is in volume, not in the moat. From the trough, diluted EPS rebuilt to $13.67 (2025), +84%.

Composition. MIS growth is cyclical issuance volume layered on the secular growth of global debt outstanding — largely organic, transactional, and lumpy. MA growth is the higher-quality kind: mostly organic, recurring subscription compounding (ARR +8%, KYC +15%), supplemented by small bolt-ons (Numerated in 2024). The deliberate retirement of MA transaction revenue (–18%) in favor of ARR is a quality-improving mix shift.

Forward opportunities. (1) The 2026 maturity wall plus AI-capex/hyperscaler IG issuance support near-term MIS volume; (2) secular global-debt growth underpins long-term MIS; (3) MA private-credit/private-markets data and regulation-driven KYC/AML demand; (4) AI monetization — GenAI assistants, decision-grade data licensing into Copilot/Excel/Claude, LLM-ready data APIs — which expands MA’s addressable market; (5) international expansion via local-agency stakes (China CCXI, India, LatAm via ICR Chile, Middle East/Africa via MERIS). Q1 2026 evidence: lending-suite ARR +18%, a growing pipeline of large institutions consuming “agent-ready intelligence.”

The honest caveat. Growth is bifurcated. MA’s recurring ARR is the part to underwrite with confidence. MIS faces a probable 2026 issuance-comp air-pocket as 2025’s strong issuance laps — management itself flagged transaction revenue down 56% in Q1 2026 (a ~1pt headwind) and guided MA toward the low end of its mid-single-digit range after divesting its Regulatory Solutions business (ARR growth unchanged). The headline EPS algorithm also leans on buybacks (shares 187M → 177.5M).

Verdict (Growth quality): HIGH-QUALITY, mostly organic, with credible double-digit EPS power, tempered by genuine MIS cyclicality and a likely 2026 comp air-pocket. MA’s recurring compounding is the durable core; MIS adds a high-margin cyclical kicker structurally supported by the refinancing wall and secular debt growth. Not the fastest grower in financials, but among the most durable.

6. Financial Quality

Moody’s financial quality is, in a word, exceptional — and improving off the 2022 trough.

Several quality markers stand out. Margins. A 74% gross margin and a ~51% adjusted operating margin reflect the toll-road economics of MIS and operating leverage at MA; incremental operating margins ran ~77% in FY2025. ROIC of 26% is comfortably above any reasonable cost of capital and is rising as the issuance recovery flows through. Cash conversion is consistently above 1.0x net income (FY2025 CFO $2,901M vs. net income $2,459M), with negligible capex — this is a business that turns earnings into distributable cash almost dollar-for-dollar.

Balance sheet. Cash $2.4B, total debt $7.35B, net debt ~$4.6B = ~1.2x EBITDA — modest, investment-grade leverage with ample headroom. The one item that looks alarming on a screen is negative tangible common equity: goodwill ($6.4B) plus intangibles ($1.9B) exceed total equity ($4.2B). This is not a red flag here — it is the arithmetic of a serial (modest) acquirer that has bought back $14.98B of treasury stock over time. The franchise’s value is its regulatory license and reputation, not its book; tangible book is the wrong lens for a 26%-ROIC annuity. Net debt/EBITDA, interest coverage (operating income $3.46B vs. interest $281M ≈ 12x), and FCF/debt are the right metrics, and all are strong.

Margin trajectory and operating leverage. The clearest evidence of the franchise’s quality is the incremental margin: in FY2025, ~77% of every incremental revenue dollar dropped to operating income. That is the signature of a business whose costs are largely fixed (analysts, data infrastructure, software development) and whose marginal product (one more rating, one more subscription seat) is nearly free to deliver. It cuts both ways — the same operating leverage that drove margins from 36.5% (2022) to 44.9% (2025) on the way up also amplified the downside in the freeze. But across a full cycle, the structural margin trend is upward, now aided by AI lowering the cost to produce and surveil ratings (MIS adjusted margin +350bps YoY).

Working capital and cash dynamics. The business runs a modest negative-to-neutral working-capital position typical of a subscription/services model — deferred revenue ($1.7B) is a source of float (customers pre-pay subscriptions), partly offset by receivables. The cash-conversion cycle (~80 days) is unremarkable and stable. There is no inventory, no meaningful PP&E, and no capital-intensity drag — the reason FCF tracks net income so tightly.

Quality of earnings. Clean. The 2022 figures are the distorted year (issuance trough + restructuring) and should not be treated as run-rate; FY2024–25 margins (42–45% GAAP) are the normalized recovery. We found no large one-time gains flattering recent EPS — the earnings growth is operational. The gap between GAAP and adjusted figures is driven by acquisition-related amortization and occasional restructuring, which is reasonable for this business. SBC at $232M (~3% of revenue) is moderate and more than offset by buybacks. The effective tax rate (~21% in 2025) is normal; the 2023 dip to ~17% was a discrete benefit and is not run-rate. Net: this is among the cleanest large-cap earnings profiles in financials — no aggressive revenue recognition (the issuer-pays fee is earned at a clear point), no capitalized-cost games, no pension or insurance-reserve estimation risk.

Verdict (Financial quality): Economics improve with scale and are improving with the cycle. Best-in-class margins, 26% ROIC, near-perfect cash conversion, a conservative balance sheet, and clean earnings. The only nuance — cyclicality — shows up in the level of earnings (the 2022 dip), never in their quality.

7. Capital Allocation

Capital allocation is a clear thesis positive, with one minor blemish.

Returns of capital. In FY2025 Moody’s returned ~$2.41B (~83% of FCF) — $701M of dividends plus $1.7B of buybacks — while reinvesting the remainder in a 26%-ROIC business. The dividend payout is a conservative ~28% of EPS ($3.91/share, on a long consecutive-raise record), leaving capacity. Buybacks have driven a steady net share-count reduction from 187M (2020) to ~177.5M (2025), more than offsetting the $232M of annual SBC. Management raised FY2026 buyback guidance by $500M to ~$2.5B on the Q1 call — and is doing so into a de-rated stock (below its 200-day average), which is favorable timing.

M&A. The cadence is disciplined. The large deal was RMS ($2.0B, 2021) — bought near a cycle peak, and the one place where return discipline is opaque (Moody’s has never transparently justified the multiple on a returns basis; we find no evidence of value destruction, but no evidence of a home run either). Since then it has been small, strategically coherent bolt-ons: Cape Analytics (geospatial AI for insurance, Jan 2025), Numerated (lending, 2024), and emerging-market ratings reach (ICR Chile, MERIS in the Middle East/Africa). FY2025 M&A cash was only ~$206–246M. The skew toward AI/data assets that feed MA recurring revenue is exactly the right direction.

Incentive alignment (DEF 14A, filed 2026-03-04). CEO Robert Fauber’s 2025 total compensation was $18.1M. Long-term incentives — the dominant element — are 60% performance shares / 20% options / 20% RSUs, with performance shares vesting on three-year cumulative adjusted EPS (the 2025 cycle hit 120% of target). The annual cash bonus is funded by growth in MIS operating income, MA operating income, and MA ARR — i.e., the recurring-revenue flywheel the bull case rests on. Say-on-pay passed at ~87%. The yellow flag: the headline long-term metric is absolute adjusted EPS, not relative TSR or an explicit ROIC hurdle, which lets the metric be flattered by buybacks. It is a soft spot, not a red flag — the bonus drivers are the right operating metrics, and pay is heavily equity- and performance-weighted.

Verdict (Capital allocation): STRONG / high-quality. Reinvestment at 26% ROIC, disciplined AI/recurring-revenue bolt-ons, a conservative payout, consistent share shrinkage, low leverage, and buybacks executed into weakness. Caveats: RMS price discipline was opaque, and the LTI metric lacks a relative-TSR/ROIC component. Net positive.

8. Changes and Headwinds — Last Two Years

Strategic positives. (1) The Microsoft generative-AI partnership has matured from an internal “Moody’s CoPilot” (deployed to ~14,000 employees) into client-facing “Research Assistant” and now agentic AI products — productizing AI into MA as a potential new recurring-revenue vector. (2) The Anthropic/Claude integration (Q1 2026) makes Moody’s agentic credit and compliance workflows natively available inside Claude — a first-of-its-kind distribution channel for licensed Moody’s content. (3) Disciplined bolt-on M&A skewed to AI/data (Cape Analytics, Numerated) and EM ratings reach (ICR Chile, MERIS). (4) The issuance environment normalized post-2022, with MIS rebounding to record 2024–25 levels and MA recurring revenue compounding steadily. (5) Governance/management stability — CEO Fauber and CFO Noemie Heuland are both stable; the board added director Lisa Sawicki (ex-PwC) in early 2026; the filing record is clean (no litigation 8-Ks, no covenant events, no surprise departures).

Headwinds. (1) MIS cyclicality — the central earnings risk; a 2022-style issuance freeze would compress earnings hard, and 2026 guidance assumes continued favorable issuance against tough comps (Q1 2026 transaction revenue was down 56% on the prior-year comp). (2) The de-rating itself — the stock is down ~12% YTD, below its 200-day average, with negative momentum and a negative one-year Sharpe ratio, even as results set records; the market is pricing some combination of issuance normalization and AI risk. (3) The AI/disintermediation narrative overhanging all financial-data names. (4) Regulatory tail risk to the issuer-pays model (live since 2008, never dislodged).

Verdict (Changes): NET STRENGTHEN. Business momentum, AI productization, disciplined M&A, and management stability outweigh cyclicality and valuation headwinds. The principal risk is external (the issuance cycle), not company-specific deterioration.

9. Risk Analysis

The risk profile is dominated by one external, cyclical, recoverable risk (issuance volumes) and one valuation risk (paying a full multiple). The structural, business-destroying risks (competitive displacement, regulatory abolition of issuer-pays, AI obsolescence of ratings) are all low-probability. There is no realistic catastrophic-loss scenario for a debt-free-of-leverage-concerns, 26%-ROIC annuity.

10. Valuation Discussion (Embedded Expectations)

This section discusses valuation only as embedded expectations and scenarios. No price target, no recommendation.

Where the multiple sits. At ~$448, Moody’s trades at ~32x trailing EPS ($13.93 TTM), ~27x forward EPS (FY2026 guide midpoint $16.70), ~21x EV/EBITDA, and ~11x EV/Sales, with a ~3.8% free-cash-flow yield. In absolute terms that is a premium multiple — appropriate for a wide-moat, 26%-ROIC, double-digit compounder, but a multiple that demands the franchise keep performing. The crucial context: on an own-history valuation-percentile screen, MCO sits at the 53rd percentile of its own ~10-year valuation range (P/E 46th, P/B 54th, P/S 60th) — this is mid-of-range, not the peak-of-its-own-history pattern seen in some quality names. The stock has de-rated in 2026, with the absolute P/E falling from ~37x at the FY2025 year-end close ($511) to ~32x today.

Embedded-expectations (reverse DCF). At an EV of ~$84B against ~$3.0B of free cash flow to the firm, a 9–10% required return implies the market is pricing only ~5.4%–6.4% perpetual FCF growth. For a franchise whose drivers are (i) secular growth in global debt outstanding, (ii) MA recurring ARR compounding high-single-digit at 95% retention, and (iii) ~1%/year share shrinkage, that embedded growth rate is undemanding — comfortably achievable across a normal cycle. In other words, the current price does not require an issuance super-cycle or AI-driven re-acceleration; it requires the franchise to keep being itself.

Scenarios (illustrative, not targets):

The asymmetry favors the patient buyer: the bear case (~$330, ~–26%) requires both a cyclical issuance disappointment and multiple compression, while the base case roughly holds the line and the bull case offers ~+30%. The dominant variable is the MIS issuance cycle; the swing variable for the multiple is whether the market’s AI fear about MA proves founded.

Peer-multiple context. Moody’s trades in line with — and in some cases below — the “convention-toll” cohort it belongs to, which is the relevant comp set rather than diversified financials or banks:

The pattern is instructive: the market pays up for convention/standard tolls (MSCI, VRSK, SPGI, MCO) and down for pure data vendors (FDS) — precisely the distinction this report draws between MIS (coordination toll) and the data-vendor caricature the AI sell-off applies to MCO. Within the cohort, MCO sits at the lower end of the toll-collector range despite owning half the ratings duopoly, reflecting both its lack of an index business and the 2026 de-rating. It is not the cheapest data name (FDS is), but it is the cheapest ratings name relative to its own history.

Sensitivity — the two levers. The price is most sensitive to (i) the level of normalized EPS (driven by the MIS issuance cycle) and (ii) the multiple (driven by the AI/growth narrative). A 1-turn change in the forward multiple is worth ~$17/share; a 5% change in normalized EPS is worth ~$22/share at a constant 27x. The bear case requires both to move adversely at once; the base case requires neither.

What the market is underwriting correctly vs. incorrectly. Correctly: that MIS is cyclical and 2026 faces tough issuance comps; that a 32x trailing multiple has limited margin of safety against a downturn; that MA’s Data & Information layer faces real AI pressure. Potentially incorrectly: that AI is a net threat to a company ~70% of whose profit is in AI-immune ratings; that 2025’s issuance strength is a peak rather than the leading edge of a multi-year refinancing wall; and that a de-rating to a mid-of-own-range multiple is warranted for a franchise setting earnings records with 26% ROIC.

11. Variant Perception

Consensus belief. Moody’s is a great business at a full price, with two overhangs: (1) 2025’s issuance strength is a cyclical peak and 2026 comps are hard, and (2) generative AI threatens the data/analytics moat across the entire financial-information complex. The stock has been sold accordingly — down ~12% YTD, negative momentum, abandoned by the trend-followers.

Strongest bull case. The market is mis-pricing the segment mix of the AI risk. ~70% of segment profit sits in MIS, a regulatorily-protected coordination monopoly that AI cannot disintermediate — and that AI actually makes more profitable by lowering production cost (margins +350bps to 63.6%). The AI-exposed segment (MA) is only ~30% of profit and is itself monetizing AI (Microsoft Copilot, Anthropic/Claude, decision-grade data licensing) rather than being commoditized. Meanwhile the refinancing maturity wall (~$2.78T in 2026) and secular debt growth support MIS volumes, MA ARR compounds at 95% retention, and the company returns ~80%+ of FCF while buying back stock into a de-rated multiple. You are buying a wide-moat compounder at the 53rd percentile of its own valuation range with embedded growth expectations of only ~5–6%.

Strongest bear case. The multiple is the problem. At 32x trailing, MCO prices in continuation, and the franchise’s earnings level is cyclically elevated by a strong issuance environment that is, by definition, mean-reverting. A genuine 2022-style freeze would take EPS down sharply and compress the multiple — a double hit. On AI, the bear says the threat is not zero even for the core: over a long horizon, AI-driven private-credit and direct-lending growth could erode the share of financing that flows through publicly-rated bond markets, and MA’s Data & Information layer (the most substitutable, $912M) faces real pricing pressure as LLMs commoditize generic data. And insiders, notably, did not buy the YTD dip.

The 3–5 assumptions that matter most:

1. MIS issuance volumes hold up across the cycle (maturity wall + secular debt growth vs. a rate-shock freeze). The dominant earnings variable.
2. MA ARR durability — does ~95% retention and high-single-digit ARR growth persist, or does AI crack Data & Information retention/pricing?
3. The AI threat is mis-located onto MA (~30% of profit) rather than the AI-immune MIS core (~70%).
4. Multiple stability — does a mid-of-own-range 32x hold, or does the de-rating continue toward the historical low end?
5. Capital-return discipline continues (buybacks into weakness, no large peak-cycle M&A).

Factor-positioning read (the tape as evidence). The factor model places MCO as a high-beta (~1.16–1.38), low-volatility-and-quality-leaning name with negative momentum (–0.22) and a negative one-year Sharpe — i.e., an out-of-favor quality stock the momentum crowd has left, currently with a small recent bounce (~+4% over three months; +15.9% ann.). It loads negatively on InterestRate (–0.13), consistent with the issuance-sensitivity story (higher rates → less issuance → lower MIS revenue). The factor-similar peer set is led by S&P Global (0.957 similarity — the twin), then Broadridge and Equifax. The positioning is consistent with a value-in-quality setup: a structurally superb franchise that has been sold to a reasonable point on cyclical and narrative fears, not a deteriorating business in a justified downtrend. That distinguishes it from a falling knife.

12. Fact vs. Interpretation

13. Open Questions

1. MIS issuance elasticity — what is the precise revenue sensitivity to a 10–20% decline in global issuance volumes, and how hard is the 2026 comp against record 2025? (Corporate/leveraged finance is the swing line.)
2. MA Data & Information retention/pricing — the most AI-substitutable LOB ($912M); is retention holding at price, or quietly eroding? The cleanest bear falsification signal.
3. AI data-licensing revenue — when does the Microsoft/Anthropic/Copilot monetization become a disclosed, quantified revenue line rather than a strategic narrative?
4. Private credit — net effect on MIS: durable ratings demand (insurer-held private credit seeks ratings) vs. disintermediation of public bond markets.
5. RMS (2021) returns — never transparently disclosed; was the $2.0B peak-cycle deal value-accretive?
6. Issuer-pays regulatory risk — dormant but permanent; any sign of revival in the US or EU?

14. What Must Be True

For the bull case to be right:

• MIS issuance volumes prove resilient across the cycle — the maturity wall and secular debt growth more than offset cyclical softness — so MIS earnings level is not a one-cycle peak.
• MA sustains high-single-digit ARR growth at ~95% retention, and AI proves to be a monetization channel (licensing, agents) rather than a substitute — visible in stable-to-rising MA organic growth and, eventually, disclosed AI revenue.
• Falsification test: Two-plus consecutive quarters of decelerating MA organic/ARR growth with Data & Information retention or pricing visibly cracking — that would confirm the AI-substitution bear and break the “AI is mis-located” thesis. Separately, MIS recurring (surveillance) revenue falling would signal the bond stock itself is shrinking.

For the bear case to be right:

• A genuine, sustained issuance downturn (a rate shock or risk-off freeze à la 2022) compresses MIS earnings and the multiple simultaneously, exposing the 32x trailing price.
• AI and private-credit growth structurally erode the share of financing that flows through publicly-rated markets, and commoditize MA’s data layer.
• Falsification test: MIS transaction revenue grows through a rate-up environment (proving refinancing-wall non-discretionary demand dominates), MA organic growth holds or accelerates, and the multiple re-rates rather than compresses — which would invalidate the “cyclical-peak-at-a-full-price” bear.

15. Source Appendix

See MCO_source_appendix.md (Appendix B of the combined report) for the full source list with URLs and access dates.

Primary sources: Moody’s FY2025 10-K (filed 2026-02-18) and FY2023 10-K (segment, LOB, ARR, geographic, Non-GAAP tables); DEF 14A proxy (filed 2026-03-04); Form 4 corpus (2025–2026); 8-K corpus (2024–2026); Q1 2026 earnings call transcript (2026-04-22) and FY2025 earnings/guidance (2026-02-18). Quantitative: third-party fundamental-data and factor-model services (financial statements, ratios, enterprise value, valuation multiples, own-history valuation percentiles, factor loadings). Industry/qualitative: SEC OCR 2024 NRSRO Staff Report; S&P Global Credit Trends (maturity wall); PitchBook 2026 HY Outlook; Morgan Stanley IM, Simply Wall St, Constellation Research (AI/data-moat debate); S&P Global (SPGI) public segment disclosures for the direct-peer comparison.

This analysis carries no buy/sell recommendation and no price target. The only position taken in this document is in the clearly-labeled “Claude’s Take” block at the top, which is the author’s own subjective opinion.

APPENDIX A — Standard Diligence Questionnaire — Moody’s Corporation (NYSE: MCO)

Supplemental to the research memo. Report date 2026-06-13. Facts labeled where material.

General

What thoughtful questions have other investors asked about this company? The recurring debates: (1) Is 2025 issuance a cyclical peak? — i.e., how much of MIS’s record revenue is sustainable vs. a refinancing-wall pull-forward. (2) Does generative AI commoditize Moody’s data/research? — the question driving the 2026 de-rating across financial-information stocks. (3) Is 32x trailing earnings too much to pay for a cyclical, even a great one? (4) Can MA’s recurring growth re-accelerate, or has the cloud/subscription transition matured? (5) Does private credit grow around public ratings or feed them? (6) Why have insiders not bought a 12%-cheaper stock? The variant view in this report is that the AI fear is mis-located onto the smaller (~30% of profit) segment, while the dominant MIS profit pool is AI-immune.

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Above mid-cycle. FY2025 EPS ($13.67) is +84% off the 2022 trough ($7.44) and benefits from a strong issuance year; 2026 faces tough MIS comps (Q1 2026 transaction revenue –56% on the prior-year comp). MA earnings are not cyclical (recurring subscriptions).

Driven by external environment or internal actions? Both. MIS revenue is largely external (debt-issuance volumes, rates, risk appetite). Margin expansion (+350bps MIS YoY), the MA mix shift to ARR, AI cost leverage, and buybacks are internal.

How stable are revenues? Bifurcated: ~46% of consolidated revenue is recurring (MA ~57% recurring at ~95% retention; MIS ~36% recurring surveillance/relationship fees). The transactional ~54% (mostly MIS new-issue ratings) is the volatile portion — 2022 showed a 12% revenue / 37% EPS drawdown is possible in a freeze.

Outlook for products/services? Favorable. Ratings demand is anchored in non-discretionary refinancing (the ~$2.78T 2026 maturity wall), AI-capex/hyperscaler IG issuance, private credit, and energy transition. MA demand is driven by regulation (KYC/AML), risk management, and AI-enabled workflow adoption.

How big will this market be — growing, shrinking, domestic or international? Growing and global. Global debt outstanding grows secularly; MA’s data/analytics TAM expands with AI. >50% of revenue is non-US; MA is majority international (EMEA largest).

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Ratings: stable — a ~95% Big-Three oligopoly unchanged for 15+ years. Analytics: more competitive and AI-disrupted, but Moody’s MA competes on proprietary data/workflow rather than as a generic terminal.

How profitable is the business (ROIC, ROE)? ROIC 26.1%, ROE 14.5% (2025). MIS standalone economics are far higher (capital-light 63.6% margin). Among the most profitable franchises in finance.

How profitable is the industry — competitors, barriers? Ratings earns 60%+ margins for both S&P and Moody’s, sustained for decades — textbook durable oligopoly. Barriers: NRSRO regulatory license, the two-rating convention, century-long reputation. Analytics margins are 20–35% industry-wide.

Can the business be easily understood? Yes — a toll on debt issuance plus a subscription data/software business. The nuance is the segment-mix and cyclicality.

Can it be undermined by foreign low-cost labor? No. The moat is a regulatory license + reputation + a coordination standard, not a labor-cost structure.

Do brands matter? Decisively. “Moody’s” is the brand — investors and regulators mandate the rating by name; the reputation is the moat.

Nature of competition? Ratings: a stable duopoly (Moody’s/S&P) plus Fitch; competition is on coverage/reputation, not price. Analytics: feature/data/workflow competition vs. Bloomberg, LSEG, FactSet, S&P MI, MSCI.

Customers’ switching costs? MIS: high — switching raters mid-program invites market suspicion; the two-rating convention locks the incumbent pair. MA: moderate-to-high — embedded workflow software (KYC, banking, insurance) and proprietary data feeds carry real switching friction (~95% retention).

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? Yes — the NRSRO license, brand/reputation, and the Orbis/BvD database are worth vastly more than carried; the franchise’s value is overwhelmingly intangible/off-balance-sheet.

Off-balance-sheet liabilities? Operating leases and ordinary contingencies; no unusual exposures identified. Litigation risk is the ordinary background for a rating agency (post-2008 settlements long resolved).

How conservative is the accounting? Clean. GAAP-to-adjusted bridges are mainly acquisition amortization and occasional restructuring. No large one-time gains flattering recent EPS. 2022 is the distorted (trough) year, not run-rate.

How CapEx-hungry? Minimal — ~$110M capex on $7.7B revenue (~1.4%). Capital-light; near dollar-for-dollar earnings-to-cash conversion.

Capital Allocation & Management

How much FCF, and how is it used? ~$2.9B FCF (2025); ~83% returned (~$0.7B dividends + ~$1.7B buybacks); the rest reinvested at 26% ROIC plus small bolt-on M&A. Philosophy: reinvest in the franchise, return the bulk via low-payout dividend + buyback.

Significant acquisitions recently? Disciplined bolt-ons: Cape Analytics (2025, geospatial AI/insurance), Numerated (2024, lending), ICR Chile + MERIS (EM ratings). The large deal was RMS ($2.0B, 2021) — strategically sound, returns never transparently disclosed.

Buying back shares? Yes — steadily; share count 187M (2020) → ~177.5M (2025); FY2026 buyback guidance raised to ~$2.5B, executed into a de-rated multiple.

Issuing large amounts of stock to insiders? No — SBC ~$232M (~3% of revenue), more than offset by buybacks. Net share count falls.

Compensation policy? CEO 2025 pay $18.1M; LTI = 60% performance shares (3-yr cumulative adjusted EPS) / 20% options / 20% RSUs; annual bonus on MIS OI + MA OI + MA ARR. Say-on-pay ~87%. Yellow flag: absolute EPS (buyback-flatterable), no relative-TSR/ROIC hurdle.

Motivations of management? Heavily equity-aligned; metrics track the operating model. Stable, long-tenured team (CEO Fauber, CFO Heuland).

Valuation & Market Data

ADR, MLP, or K-1 issuer? No — US C-corp, common stock (NYSE: MCO); standard 1099 dividends.

Dividend policy? Conservative ~28% payout; ~$3.91/share (2025); long consecutive-raise record; ~0.9% yield.

How profitable? Among the most profitable in finance — 74% gross, ~51% adjusted operating margin, 26% ROIC.

Net income diverging from cash from operations? No — CFO ($2,901M) exceeds net income ($2,459M); cash conversion >1.0x. Healthy.

Risks & Downside

What would cause the stock to decline? A debt-issuance downturn (rate shock/risk-off) compressing MIS; multiple compression off a 32x trailing base; a credible AI-substitution data point in MA; or a sentiment-driven continuation of the 2026 de-rating.

Risk of catastrophic loss? Very low. Profitable, cash-generative, investment-grade (net debt ~1.2x EBITDA), capital-light. The franchise endured 2008 and 2022 intact.

Chance of total loss? Negligible — would require simultaneous abolition of the issuer-pays/NRSRO regime and the collapse of public debt markets. Not a realistic scenario.

Recent News & Events

Has the business environment changed recently? Yes, favorably on fundamentals: issuance normalized post-2022; record FY2025 and Q1 2026; AI productization advancing (Microsoft Copilot, Anthropic/Claude agentic workflows). Offsetting: a ~12% YTD 2026 stock de-rating on cyclical/AI narrative fears.

Significant acquisitions? Cape Analytics (Jan 2025) and EM ratings reach (ICR Chile, MERIS); divested Regulatory Solutions (closed April 2026).

Change in accounting policies? None material identified.

Recent changes — markets, facilities, management? Board addition (Lisa Sawicki, 2026); 2001 stock-incentive-plan amendment (Dec 2025); continued international/EM ratings expansion; AI-product rollout. Management and CFO stable.

APPENDIX B — Source Appendix — Moody’s Corporation (NYSE: MCO)

Report date 2026-06-13. Primary sources first.

Primary filings (SEC EDGAR; local corpus output/MCO/sources/)

• Moody’s Corporation FY2025 Form 10-K, filed 2026-02-18 (mco-20251231.htm) — segment & line-of-business revenue, transaction/recurring split, MA ARR table, geographic mix, segment adjusted operating income/margin, Non-GAAP reconciliation, risk factors. https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001059556
• Moody’s FY2023 Form 10-K, filed 2024-02-14 (mco-20231231.htm) — 2022 issuance-trough framing.
• Moody’s FY2024 Form 10-K, filed 2025-02-14 — comparative segment data.
• Moody’s DEF 14A proxy, filed 2026-03-04 (mco-20260304.htm) — executive compensation, LTI metrics (3-yr cumulative adjusted EPS; MIS OI / MA OI / MA ARR bonus drivers), say-on-pay ~87%, board composition, Summary Compensation Table.
• Form 4 corpus, 2025-01 through 2026-06-08 (output/MCO/sources/4/) — insider transactions (no open-market code-P purchases; routine 10b5-1 vest/exercise-and-sell).
• 8-K corpus, 2024–2026 (output/MCO/sources/8-K/) — quarterly earnings (Item 2.02); 2025-12-19 stock-incentive-plan amendment; 2026-01-12 director election (Lisa Sawicki); 2026-02-18 FY2025 results + FY2026 guidance; 2026-04-22 Q1 2026 results.

Earnings calls / transcripts

• Q1 2026 earnings call transcript, 2026-04-22 — record quarter; both segments +8%; adjusted operating margin 53.2%; adjusted EPS $4.33 (+13%); buyback guidance raised $500M to ~$2.5B; Anthropic/Claude agentic-workflow integration; lending-suite ARR +18%; Regulatory Solutions divestiture; transaction revenue –56% comp.
• FY2025 / Q4 2025 earnings call & guidance, 2026-02-18 — FY2026 adjusted EPS guide $16.40–$17.00. Motley Fool transcript: https://www.fool.com/earnings/call-transcripts/2026/02/18/moodys-mco-q4-2025-earnings-call-transcript/ ; guidance summary: https://www.themarketsdaily.com/2026/02/18/moodys-nysemco-updates-fy-2026-earnings-guidance.html

Quantitative data services

• Third-party fundamental-data service — income statement, balance sheet, cash flow, profitability/credit/liquidity ratios, enterprise value, valuation multiples, earnings-call transcripts (FY2020–2025; accessed 2026-06-13).
• Own-history valuation percentiles — composite 53rd, P/E 46th, P/B 54th, P/S 60th (third-party valuation-percentile data; accessed 2026-06-13).
• FactorsToday — factor loadings (Market, LowVol, Quality, Momentum, InterestRate), risk-adjusted leaderboard, related-stocks (SPGI 0.957). https://www.factorstoday.com/api (accessed 2026-06-13).

Industry & qualitative sources

• SEC Office of Credit Ratings, 2024 NRSRO Staff Report, https://www.sec.gov/files/jan-2025-ocr-staff-report.pdf (NRSRO registrants, outstanding-ratings shares; accessed 2026-06-13).
• “Big Three credit rating agencies,” https://en.wikipedia.org/wiki/Big_Three_(credit_rating_agencies) (~95% Big Three / ~80% S&P+Moody’s international share; accessed 2026-06-13).
• “New players are finally disrupting the credit rating sector,” European CEO, https://www.europeanceo.com/finance/new-players-are-finally-disrupting-the-credit-rating-sector/ (share figures; accessed 2026-06-13).
• S&P Global Ratings, Credit Trends — global refinancing / maturity wall, https://www.spglobal.com/ratings/en/ (2026 maturities ~$2.78T; accessed 2026-06-13).
• PitchBook, 2026 US High-Yield Outlook, https://pitchbook.com/news/articles/2026-us-high-yield-outlook-volume-to-tick-higher-amid-looming-maturity-wall (HY issuance $340–410B; accessed 2026-06-13).
• Morgan Stanley Investment Management, “When every data business looks like a target,” https://www.morganstanley.com/im/en-us/financial-advisor/insights/global-equity-observer/when-every-data-business-looks-like-a-target.html (AI-disruption-to-data-moats debate; accessed 2026-06-13).
• Simply Wall St, “Is Moody’s generative-AI push altering the investment case,” https://simplywall.st/stocks/us/diversified-financials/nyse-mco/moodys/news (AI threat + Microsoft Copilot integration; accessed 2026-06-13).
• Constellation Research, “How Moody’s is thinking about data moats, AI strategy, token costs,” https://www.constellationr.com/insights/news/how-moodys-thinking-about-data-moats-ai-strategy-token-costs (Orbis/BvD data moat; accessed 2026-06-13).
• M&A: TechCrunch, “Moody’s agrees to acquire Cape Analytics,” https://techcrunch.com/2025/01/13/moodys-agrees-to-acquire-cape-analytics-which-develops-geospatial-ai-for-insurance-providers/ (2025-01-13); ICR Chile, https://finance.yahoo.com/news/moodys-fortifies-position-latin-america-121700604.html (2025).
• Moody’s / Microsoft generative-AI partnership, https://ir.moodys.com/press-releases ; https://aibusiness.com/generative-ai/generative-ai-optimize-insights-for-moody-s-global-workforce.

Peer comparison

• S&P Global (NYSE: SPGI) public filings — used as the direct-peer comparison for ratings-duopoly economics, Market Intelligence vs. Moody’s Analytics segment margins, NRSRO share, and the maturity-wall framing. https://investor.spglobal.com